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Abstract
Hepatitis C virus (HCV) requires the liver specific micro-RNA (miRNA), miR-122, to repli-
cate. This was considered unique among RNA viruses until recent discoveries of HCV-
related hepaciviruses prompting the question of a more general miR-122 dependence.
Among hepaciviruses, the closest known HCV relative is the equine non-primate hepaci-
virus (NPHV). Here, we used Argonaute cross-linking immunoprecipitation (AGO-CLIP) to
confirm AGO binding to the single predicted miR-122 site in the NPHV 5’UTR in vivo. To
study miR-122 requirements in the absence of NPHV-permissive cell culture systems, we
generated infectious NPHV/HCV chimeric viruses with the 5’ end of NPHV replacing ortholo-
gous HCV sequences. These chimeras were viable even in cells lacking miR-122, although
miR-122 presence enhanced virus production. No other miRNAs bound this region. By ran-
dom mutagenesis, we isolated HCV variants partially dependent on miR-122 as well as
robustly replicating NPHV/HCV variants completely independent of any miRNAs. These
miRNA independent variants even replicate and produce infectious particles in non-hepatic
cells after exogenous delivery of apolipoprotein E (ApoE). Our findings suggest that miR-
122 independent HCV and NPHV variants have arisen and been sampled during evolution,
yet miR-122 dependence has prevailed. We propose that hepaciviruses may use this mech-
anism to guarantee liver tropism and exploit the tolerogenic liver environment to avoid clear-
ance and promote chronicity.
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Author summary
It has been known for more than 10 years that the hepatitis C virus (HCV) genome binds
two copies of the liver-specific microRNA (miRNA), miR-122. But until recently, it was
unknown whether this interaction was unique to HCV or also conserved among other
hepaciviruses. Now, due to our expanded view of the hepacivirus family, we know that
most, if not all, hepaciviruses have at least one predicted miR-122 binding site in their 5’
untranslated region (5’UTR). In this study, we aimed to obtain a broader understanding
of hepacivirus/miR-122 interactions and determine how miR-122 dependence influences
tissue tropism. To do this, we chose to study the equine non-primate hepacivius (NPHV),
the closest relative of HCV. NPHV has one predicted miR-122 site in its 5’UTR. We show
that minor changes in the 5’UTR of HCV and NPHV/HCV chimeras weaken or obviate
the need for miR-122 for virus replication. Overall, our data suggest that miR-122-inde-
pendent hepaciviruses have likely been sampled during evolution, but hepaciviruses may
have been selected to utilize miR-122 to restrict replication to the tolerogenic liver envi-
ronment to help avoid immune clearance.
Introduction
Chronic HCV infection is one of the most common liver diseases with ~71 million people per-
sistently infected globally; a significant number of those will develop cirrhosis or liver cancer
[1]. The binding of liver specific miR-122 to HCV RNA is essential for viral replication [2].
This interaction is unusual in that two molecules of miR-122 bind to the 5’ untranslated region
(5’UTR) of HCV using both seed and auxiliary pairing [3,4]. It is well established that HCV
viral load can be dramatically decreased by inhibiting miR-122 in cell culture, chimpanzees or
patients, making antagonists of miR-122 a first-in-class antiviral strategy [5–7]. Several func-
tions have been suggested for the HCV/miR-122 interaction: (i) Binding of the AGO/miR-122
complex can protect the uncapped HCV RNA from degradation by cellular exonuclease XRN1
and/or XRN2 [8–10]. (ii) AGO/miR-122 binding can increase HCV internal ribosome entry
site (IRES)-driven translation, thus promoting the HCV replication [11]. This process possibly
works by switching the IRES from “closed” to “open” conformation [12,13]. (iii) Competition
between miR-122 and poly(rC)-binding protein (PCBP2) that binds and circularizes HCV
RNA may act as a switch between translation and replication [14]. (iv) In addition, using
AGO-CLIP and RNA-seq, we recently showed that HCV RNA can act as a miR-122 “sponge”
in a positive feed-back loop to de-repress cellular mRNAs normally targeted by miR-122,
thereby indirectly regulating hundreds of genes [15].
Until recently, the miRNA dependence of HCV was considered unique among viruses,
even for viruses possessing similar IRESs. However, we recently demonstrated that pesti-
viruses, such as the important veterinary pathogens bovine viral diarrhea virus (BVDV) and
classical swine fever virus (CSFV), similarly are dependent on the cellular miR-17 family,
although binding occurs on the viral 3’UTR [16].
The unique GB virus B (GBV-B) isolate was the only known HCV-related hepacivirus until
2011. Using replicon systems, GBV-B appears to be only partially dependent on miR-122 [17].
However, recent discoveries have identified a plethora of HCV-related viruses in horses,
rodents, bats, monkeys, and cows [18–25], most if not all of which contain miR-122 seed sites
in the 5’UTR. However, the miR-122 requirement has not been investigated for these viruses,
as no cell culture systems have been established [24,26].
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The equine non-primate hepacivirus (NPHV) shares the highest sequence homology to
HCV [18,27]. The genome structure of NPHV resembles HCV, with a long open reading
frame (ORF) that can be translated into a 2942 amino acid long polypeptide. The polypeptide
is predicted to be cleaved into the ten viral proteins C, E1, E2, p7, NS2, NS3, NS4A, NS4B,
NS5A, and NS5B. An IRES structure similar to that for HCV was predicted for the NPHV
5’UTR, but with a much longer stem loop 1 (SL1) structure and only one predicted miR-122
binding site. Using NPHV IRES reporter systems, we previously showed a pro-translational
role for miR-122 [28].
Here, we aimed to obtain a broader understanding of hepacivirus miRNA dependence and
how this might influence tissue tropism. To understand miR-122 requirements for NPHV, we
used AGO-CLIP in vivo to pinpoint the miRNA interactome on viral RNA, and developed via-
ble NPHV/HCV 5’UTR chimeras. This approach suggested that NPHV is only partially depen-
dent on miR-122. Encouraged by this result and to determine whether miRNA independent
hepaciviruses are viable, we randomized the miRNA seed site of these chimeras and HCV in
an attempt to develop miRNA independent viruses. Our results indicated that hepaciviruses
have the potential to escape miRNA requirements and break the liver-specific tissue tropism
barrier. It appears that such variants must have been sampled during hepacivirus evolution.
Interestingly, miR-122 dependence still has been strongly selected, possibly to leverage the tol-
erogenic liver environment to establish and maintain chronic infection.
Results
NPHV interacts with miRNAs at conserved miR-122 sites in vivo
To investigate putative NPHV/miR-122 interactions, we performed AGO-CLIP on liver
biopsies from two NPHV infected horses. Although sequence coverage on viral RNA was
much lower compared to highly infected HCV cell cultures [15] negating our ability to
unambiguously identify interacting miRNAs [16] (Fig 1A), this assay identified regions
with AGO/miRNA interactions across the NPHV genome. Interestingly, all significant
peaks perfectly overlapped the four conserved miR-122 sites; one in the 5’UTR, one in
NS5A and two in NS5B (Fig 1B). These data strongly suggest interaction with miR-122 dur-
ing NPHV infection in vivo.
NPHV/HCV chimeras containing regions of the NPHV 5’UTR can
establish replication and virus production in Huh-7.5 cells
To functionally characterize NPHV miR-122 requirements in the absence of a cell culture sys-
tem supporting NPHV replication, we set out to establish NPHV/HCV chimeras based on the
HCV genotype 2a recombinant J6/JFH Clone2 [29]. We constructed four different NPHV/
HCV chimeras to test regions of the HCV 5’UTR that could be replaced by NPHV (Fig 2A).
Following transfection of these chimeric genomes into Huh-7.5 cells, we assayed viral replica-
tion by staining for NS5A positive cells and measured virus production by limiting dilution
(TCID50; Fig 2B and 2C). Replacement of the entire 5’UTR or IRES region (NPHV-5’UTR and
NPHV-IRES) abolished replication completely, even when followed for 29 days. In contrast,
NPHV-SL1 infection spread similarly to the parental HCV construct, although virus produc-
tion was slightly delayed (Fig 2B and 2C). This indicated that exchange of SL1 had only lim-
ited effect on replication efficiency. Although NPHV-SL1/miRBR (microRNA Binding
Region) was attenuated, it spread to the majority of cells on day 4 with virus production
~10-fold lower than the parental HCV recombinant (Fig 2B and 2C). Since NPHV-SL1/
miRBR contains the miR-122 binding site of NPHV, this chimera was of particular interest
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for studying NPHV miR-122 dependence. We tested the IRES activity of NPHV-5’UTR and
NPHV-IRES to distinguish whether the absence of NS5A positive cells was due to block of
replication or translation. Compared to HCV, the luciferase signal driven by the NPHV-
5’UTR and NPHV-IRES variants was about 3-fold lower, but still much higher than the
background (S1 Fig). This suggests that the failure of these viruses to replicate is not due to
a block in translation.
A point mutation in the single stranded region of NPHV-SL1/miRBR
increases both replication efficiency and virus production
To determine whether the NPHV-SL1/miRBR recombinant could be further adapted, we took
supernatant on day 6 after transfection and infected naïve Huh-7.5 cells. Supernatant from
newly infected cells was then harvested on day 6 and the 5’ end of the viral genome was
sequenced. This analysis revealed a C83A mutation in NPHV-SL1/miRBR upstream of the
miR-122 site (including putative auxiliary pairing) (Fig 2D). This change did not facilitate
binding of a second miR-122 molecule; rather, it changed this region further from mirroring
the HCV seed site 1. To confirm the impact of the C83A mutation, we introduced this nucleo-
tide change into the original NPHV-SL1/miRBR genome and again transfected Huh-7.5 cells.
The mutant exhibited superior replication and virus production compared to the original
NPHV-SL1/miRBR, and was now only slightly attenuated compared to the HCV parent (J6/
JFH1-Clone2), as judged by spread of infection and virus yield (Fig 2E and 2F).
Fig 1. AGO-CLIP provides a miRNA binding map for NPHV in vivo. (A) Schematic of standard AGO-CLIP and CLEAR-CLIP.
After UV-induced cross-linking of RNA-protein complexes, precipitation of the AGO complex and RNA library preparation,
standard AGO-CLIP provides a map of AGO/miRNA interactions across the transcriptome. In CLEAR-CLIP, chimeras of
miRNAs with cellular or viral RNAs are induced. Analysis of these allows unambiguous detection of specific miRNA interactions.
(B) In vivo AGO/miRNA binding across the NPHV genome from horse liver. Binding is observed across the four miR-122 seed
sites conserved among all published isolates. Non-conserved sites present in the NZP1 isolate are indicated.
https://doi.org/10.1371/journal.ppat.1006694.g001
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Fig 2. Identification of NPHV/HCV chimeras capable of replication and infectious virus production in Huh-7.5 cells. (A) Schematic
showing the secondary structures of 5’UTR regions of HCV/NPHV chimeras that contain the NPHV entire 5’UTR (NPHV-5’UTR), IRES
(NPHV-IRES), Stem Loop 1 with microRNA Binding Region (miRBR) (NPHV-SL1/miRBR), or only SL1 (NPHV-SL1). All chimeras were
constructed on the HCV J6/JFH Clone 2 backbone. (B,E) NS5A positive cells post transfection of Huh-7.5 cells. Results represent mean
Hepaciviruses and miR-122 dependence
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miR-122 is only partially required for replication and virus production of
NPHV/HCV chimeras
Using a CRISPR engineered miR-122 knockout (KO) cell line, we next examined the ability of
NPHV-SL1/miRBR to replicate in the complete absence of miR-122. As shown before, HCV
replication was dramatically impaired in the miR-122 KO cell line (Fig 3A and 3B; [15]). The
number of NS5A positive cells and viral infectivity titers of NPHV-SL1, NPHV-SL1/miRBR
and NPHV-SL1/miRBRC83A were also reduced. Nonetheless, replication and virus production
for the NPHV/HCV chimeras was evident in cells lacking miR-122 (Fig 3A and 3B). These
results indicated that the loss of miR-122 decreased NPHV replication efficiency, but that rep-
lication could still occur in complete absence of miR-122.
miR-122 is the sole miRNA that binds to the miRBR in the NPHV 5’UTR
Next, we asked whether miRNAs other than miR-122 bind the NPHV miRBR. To this end, we
first replaced the miR-122 binding site of NPHV-SL1/miRBR with a miR-15/16-binding
±SEM from 3 independent transfections. (C,F) Infectious virus production quantified by limiting dilution assay on naïve Huh-7.5 cells post
transfection (n = 3). (D) Schematic of predicted miR-122 binding modes to NPHV and HCV. The adaptive mutation of NPHV-SL1/miRBR at
C83A site is indicated. Asterisks, *p < 0.05, **p < 0.01, Student’s t test.
https://doi.org/10.1371/journal.ppat.1006694.g002
Fig 3. Growth kinetics of wild type HCV and NPHV/HCV chimeras inΔmiR-122 Huh-7.5 cells. (A) NS5A
positive cells post transfection in Huh-7.5 (open bars) and ΔmiR-122 Huh-7.5 cells (hatched bars). Results
represent mean±SEM from 3 independent transfections. (B) Infectious virus production of supernatants from
transfected ΔmiR-122 Huh-7.5 and Huh-7.5 cells. Virus titers were quantified by limiting dilution assay on
naïve Huh-7.5 cells (n = 3).
https://doi.org/10.1371/journal.ppat.1006694.g003
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sequence. Similar to an HCV variant with both miR-122 sites replaced by miR-15 sites [15],
this virus was viable (Fig 4A). As expected, the HCV and NPHV-SL1/miRBR miR-15 variants
were unaffected by the absence of miR-122 (Fig 4A). We then used AGO-CLIP and miRNA-
target chimeras [16,30] to unambiguously identify interacting miRNAs in wt Huh-7.5 cells.
For NPHV-SL1/miRBR and NPHV-SL1/miRBR-15, miR-122 and miR-15/16, respectively,
were the only interacting miRNA species (Fig 4B). This confirmed that no other functional
miR-122 site than the single canonical site exists in the NPHV miRBR, and that no other
miRNA is binding this region.
Isolation of miR-122 independent HCV and NPHV/HCV variants
Given the only partial NPHV miR-122 dependence, we next probed whether miRNA indepen-
dent hepaciviruses with extrahepatic replication potential could be selected. We exploited the
rapid evolutionary capacity of RNA viruses to select for variants with high fitness in the pres-
ence (Huh-7.5) or absence (ΔmiR-122 Huh-7.5) of miR-122. To increase input diversity, we
randomized the miR-122 binding site of NPHV-SL1/miRBR to create NPHV-Rand. In paral-
lel, we randomized the corresponding seed site 2 of HCV to create HCV-Rand (Fig 5A). To
enrich for the most efficient variants, we took the supernatant of transfected cells when at least
50% of cells were NS5A positive to inoculate naïve cells (Fig 5A and 5B). After three passages,
we sequenced the 5’UTR of the selected viruses in the supernatant. For HCV-Rand in Huh-7.5
cells, the majority (67%) contained the wildtype miR-122 binding site, whereas the rest (33%)
contained the miR-15 binding site. Interestingly, the latter variant was identical to a synthetic
miR-122/15 construct we previously showed to be viable [15]. In ΔmiR-122 Huh-7.5 cells,
most recovered variants contained a G-rich region; among them 66% had the sequence
GGCGNG. Similarly, most recovered NPHV-Rand variants from wild type cells contained the
wild type miR-122 binding site. These had also acquired the previously described C83A muta-
tion. Surprisingly, 30% of the recovered strains had a 15-nucleotide deletion in the miRBR
region (NPHV-delta-UUGGCG). In ΔmiR-122 Huh-7.5 cells, 73% of the recovered NPHV
variants had another G-rich GGYAGG motif. One variant from each group was selected for
further characterization (Fig 5C, boxed names).
Randomized, selected HCV and NPHV/HCV chimeras replicate in the
absence of any miRNAs
We next engineered the selected sequences into the original viral genomes and tested their rep-
licative fitness in Huh-7.5 and ΔmiR-122 Huh-7.5 cells. For comparison, we also included
HCV-U3 in our analysis since this virus, which contains a fraction of the cellular U3 snoRNA
sequence in place of the SL1 region, replicates in the absence of miR-122 [31]. Similar to
HCV-U3, the selected variants HCV-S2-GGCGUG, NPHV-delta-UUGGCG and
NPHV-GGCAGG all replicated comparably in the presence or absence of miR-122 (Fig 6A).
The NPHV-based variants, however, were the most fit. HCV-122/15 replicated and spread
comparably to parental HCV in Huh-7.5 cells, but was attenuated in the absence of miR-122.
Thus, it appears that the selected NPHV-Rand variants in particular, could replicate with equal
efficiently in the absence or presence of miR-122.
The sequences of the selected G-rich random variants did not correspond to known canon-
ical miRNA seed sites. We therefore examined the ability of these variants to replicate in the
complete absence of miRNAs. Using CRISPR mutagenesis we ablated DICER to produce
ΔDICER Huh-7.5 cells. Given the critical role for DICER in cleaving pre-miRNAs [32,33], no
mature miRNAs are produced in these cells. As expected, parental HCV and HCV-122/15
were not viable in ΔDICER Huh-7.5 cells (Fig 6B). Co-transfection of a synthetic miR-122
Hepaciviruses and miR-122 dependence
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Fig 4. miR-122 but not other miRNAs binds the NPHV 5’UTR. (A) Percentage of NS5A positive ΔmiR-122 Huh-7.5 or
Huh-7.5 cells post-transfection with the indicated virus constructs. Results represent mean±SEM from 3 independent
transfections. (B) Standard AGO (left) and miRNA-specific chimera-derived (right) binding maps on the 5’ end of
NPHV-SL1/miRBR (top) and NPHV-SL1/miRBR-m15 (bottom) in Huh-7.5 cells four days post-transfection. Chimera-
Hepaciviruses and miR-122 dependence
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supported specific miRNA binding across the entire viral genome is shown below for both panels. The binding site and
chimera-supported interactions for miR-122 are shown in red and those of miR-15 in blue.
https://doi.org/10.1371/journal.ppat.1006694.g004
Fig 5. Evolutionary selection of seed site-randomized HCV and NPHV/HCV chimeras. (A) Schematic of the saturated mutagenesis approach. Left
panel: comparison of NPHV-Rand and HCV-Rand sequence with the parental strains. miRNA binding sites are shown in color. Right panel: ΔmiR-122
Huh-7.5 cells and Huh-7.5 cells were transfected by NPHV-Rand or HCV-Rand, supernatants were collected and used to inoculate naïve cells of the
same type. After three rounds of infection, the miRBR sites of enriched strains were sequenced. (B) Percentage of NS5A positive cells post-transfection
in ΔmiR-122 Huh-7.5 and Huh-7.5 cells. Results represent mean±SEM from 3 independent transfections. (C) Summary of miRBR region sequences for
NPHV-Rand and HCV-Rand enriched in ΔmiR-122 Huh-7.5 cells or Huh-7.5 cells. Residues of NPHV-SL1-miRBR and HCV corresponding to the miR-
122 seed site are shown in color (C is shown in blue, A in green, G in black, and U in red). The isolates selected for follow-up reverse genetic studies are
highlighted by boxed names.
https://doi.org/10.1371/journal.ppat.1006694.g005
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mimic (Fig 6B) rescued HCV and partially rescued HCV-122/15. In contrast, NPHV-SL1/
miRBRC83A and HCV-S2-GGCGUG replication was only slightly enhanced by miR-122 addi-
tion and NPHV-delta-UUGGCG and NPHV-GGCAGG spread with similar efficiency with or
without miR-122.
To further confirm the absence of miRNA binding for these viruses, we performed AGO-
CLIP of NPHV-delta-UUGGCG in ΔDICER Huh-7.5 cells compared to HCV and NPHV-
SL1/miRBRC83A. As expected, replication and miRNA binding was observed for HCV only after
addition of miR-122 (Fig 6C). The same result was found for NPHV-SL1/miRBRC83A despite
replication in miRNA deficient cells. No AGO/miRNA binding was observed for NPHV-delta-
UUGGCG. These data prove that these selected NPHV/HCV variants can replicate in the com-
plete absence of mature miRNAs. To determine whether miR-122 independent NPHV variants
depend on miR-122 for RNA 5’ end protection, we measured the RNA stability of HCV,
NPHV-SL1/miRBR, NPHV-SL1/miRBRC83A, and NPHV-GGCAGG in ΔmiR-122 Huh-7.5 cells.
miR-122 but not miR-430 supplementation enhanced RNA stability, but only for miR-122
dependent variants (Fig 6D). Thus, although NPHV has a much larger SL1 structure, NPHV
may still utilize miR-122 to enhance protection of the RNA from degradation. NPHV-GGCAGG,
however, apparently does not need miRNA binding to protect its RNA against 5’ degradation.
miR-122 independent NPHV/HCV variants but not those of HCV can
replicate in extrahepatic cells
miR-122 is expressed in Huh-7.5 cells [2], and reports showed that exogenous expression of
miR-122 can facilitate efficient replication of HCV in other hepatic cell lines such as Hep3B and
HepG2. Low-level replication was also observed in non-hepatic cells, including 293T kidney
cells or engineered immortalized mouse fibroblasts (iMEF) [34–37]. We therefore tested
whether the selected miR-122 independent strains could replicate in non-hepatic cells. As
expected, HCV did not replicate in 293T cells (Fig 7A). In contrast, NS5A positive cells were
observed for NPHV-SL1, NPHV-SL1/miRBRC83A and HCV-S2-GGCGUG, although at very
low frequencies. NPHV-delta-UUGGCG and NPHV-GGCAGG infected 2–5% of the cells sim-
ilar to the frequency of HCV replication in these cells upon miR-122 addition. NPHV-delta-
UUGGCG replication in 293T cells was completely abolished after addition of Daclatasvir, a
potent NS5A inhibitor [38], thus confirming its authentic replication in 293T cells (Fig 7B).
ApoE is an essential factor for infectious HCV production, including in miR-122-supple-
mented 293T cells [39]. We therefore asked whether infectious particles could be produced in
the presence of exogenous ApoE. In 293T cells transduced with a lentivirus expressing RFP-A-
poE, low levels of infectious particles were produced by NPHV-delta-UUGGCG, but not by
HCV, HCV-S2-GGCGUG or NPHV-GGCAGG, transfected cells (Fig 7C). No virus produc-
tion was observed without ApoE expression. Despite the highly attenuated particle production
in 293T-ApoE compared to Huh-7.5 cells, this proved that miRNA independent NPHV/HCV
chimeras could replicate and produce infectious progeny in non-hepatic cells.
Discussion
miR-122 has attracted great interest as a host requirement for HCV replication and hence a
potential antiviral target. Blocking miR-122 leads to prolonged viral inhibition in cell culture,
chimpanzees, and patients [5–7]. In addition, due to their long-lasting effects, miR-122 inhibi-
tors are currently being considered for special patient populations where adherence to strict
daily therapeutic regimens is problematic [40]. Therefore, it remains important to understand
the miR-122 requirement of HCV and to study resistant variants that can replicate in miR-122
depleted environments. Furthermore, both the requirement of a host miRNA for an RNA
Hepaciviruses and miR-122 dependence
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virus, and the non-classical binding of miR-122 to the HCV 5’UTR are unique. We still have
an incomplete understanding of how this interaction evolved and its biological importance.
NPHV is the closest homolog of HCV, making it an interesting comparative model. Under-
standing NPHV is also relevant given its possible association with equine liver disease [26,41].
Whereas all HCV genotypes have two conserved miR-122 binding sites, both being essential
for replication [2,3], only one binding site was predicted for NPHV [18,19]. The length of the
NPHV miRBR is comparable to that of HCV, raising the question whether a second miR-122
molecule binds in a non-canonical manner or, alternatively, a different miRNA binds this
region. Our in vivo NPHV AGO-CLIP studies confirmed miRNA binding across the miR-122
site. We therefore took advantage of replication-competent NPHV/HCV chimeras engineered
to contain parts of the NPHV 5’UTR. NPHV-SL1/miRBR was of particular interest, since it
contains the NPHV miR-122 binding site. Although NPHV-SL1/miRBR had partially attenu-
ated kinetics of viral protein accumulation and infectious virus production, more fit variants
including NPHV-SL1/miRBRC83A, NPHV-delta-UUGGCG, and NPHV-GGCAGG could be
readily selected in cell culture.
In our previous studies, we demonstrated that HCV miR-122 tropism could be replaced by
other miRNAs, such as miR-15 [15]. It was therefore possible that the increased fitness of
NPHV-SL1/miRBRC83A, NPHV-delta-UUGGCG, and NPHV-GGCAGG was acquired by
binding to alternative miRNAs. However, we found that NPHV-SL1/miRBRC83A bound only
one molecule of miR-122, and neither NPHV-delta-UUGGCG nor NPHV-GGCAGG bound
any miRNA. This was based on two observations: First, in contrast to HCV-m15, which could
not replicate in ΔDrosha Huh-7.5 cells supplemented with miR-122 [15], NPHV-SL1/
miRBRC83A was not attenuated in ΔDICER Huh-7.5 cells supplemented with miR-122 com-
pared to wt Huh-7.5 cells. The NPHV-delta-UUGGCG and NPHV-GGCAGG variants were
not attenuated in ΔDICER Huh-7.5 cells or in ΔmiR-122 Huh-7.5 cells (Fig 6A and 6B). Sec-
ond, miR-122 and miR-15, respectively, were the only miRNAs identified from AGO-CLIP
chimeras at the miRBR region of NPHV-SL1/miRBRC83A and NPHV-SL1/miRBR-m15. This
was in contrast to the identification of two independent peaks for miR-15 and miR-122 for
HCV122/15 and HCV15/122 [16]. Furthermore, no miRNA peak could be observed for
NPHV-delta-UUGGCG, even after addition of miR-122 (Fig 6C). Taken together these results
strongly suggest that newly adapted NPHV/HCV variants do not bind any other miRNA. The
cell culture selected HCV-U3 variant, which is resistant to miR-122 inhibition [31], contains a
large extended SL1 and only one miR-122 site. This 5’UTR is therefore structurally similar to
NPHV. A larger 5’-terminal SL1 may at least partially compensate for miR-122 binding, possi-
bly by preventing degradation by exonucleases. This suggests that it is possible to replace one
miR-122 seed site and obviate miR-122 dependence (at least in part) by combining a larger
SL1 with sequence changes in the miRBR region.
Fig 6. Evolutionary-selected NPHV/HCV variants replicate in the absence of any miRNA. (A)
Percentage of NS5A positive ΔmiR-122 Huh-7.5 or Huh-7.5 cells post-transfection with the indicated viral
constructs. Results represent mean±SEM from 3 independent transfections. (B) Percentage of NS5A positive
ΔDICER Huh-7.5 cells post-transfection with the indicated viral constructs with (open bars) or without (hatched
bars) co-transfection of miR-122. Results represent mean±SEM from 3 independent transfections. (C)
AGO-CLIP binding maps for HCV (top), NPHV-delta-UUGGCG (middle) and NPHV-SL1/miRBRC83A(bottom)
in ΔDICER Huh-7.5 cells 72hrs post-transfection with and without co-transfection of miR-122. Schematics of
the 5’UTRs and initial core regions of HCV and NPHV are shown below. (D) Effect of miR-122 on HCV and
NPHV/HCV RNA stability. RNA decay in ΔDICER Huh-7.5 cells was measured at the indicated times post-
transfection in the presence of either miR-122 or miR-430 (50 μM each). RNA copy number at each time point
was normalized to RNA copy number at 0hr (after transfection). The data is representative of 2 independent
biological experiments.
https://doi.org/10.1371/journal.ppat.1006694.g006
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Fig 7. Evolutionary selected NPHV/HCV variants can replicate and produce infectious particles in
non-hepatic cells. (A) Quantification of NS5A positive cells on day 2 post-transfection of 293T cells with HCV
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It is interesting to speculate why HCV requires two molecules of miR-122, whereas related
hepaciviruses such as NPHV, require only one. From the current and previous studies, it is evi-
dent that HCV replication is attenuated if only one copy of miR-122 is bound. This includes
mutants of individual seed sites [2,4,11,15,42] and the current study of HCV-S2-GGCGUG in
Huh-7.5 cells and HCV-122/15 in ΔmiR-122 Huh-7.5 cells. Interestingly, the C83A mutation
of NPHV-SL1/miRBR may induce a conformational change in the miRBR region to a more
relaxed structure (S2A and S2B Fig). Although it is tempting to speculate that this more relaxed
RNA structure might facilitate miR-122 access to the miRBR region, e.g. by providing access
to auxiliary pairing with the ACC motif at nt 87–89, the C83A mutation also facilitated more
efficient infection kinetics in the absence of miR-122 (Fig 3A and 3B), indicating that mecha-
nisms beyond miR-122 engagement may be at play. HCV, HCVG28A from a previous study
[42], NHPV-delta-UUGGCG, (S1D–S1F Fig), but not NPHV-GGCAGGG or
HCV-S2-GGCGUG (S1C and S1G Fig) have similar relaxed structures, suggesting that these
predicted secondary structures of miRBR do not necessarily correlate with miR-122 depen-
dency. We identified NPHV-SL1/miRBR variants that are either partially or completely inde-
pendent of miR-122 yet we could not identify any completely independent HCV-based
variants, presumably because seed site 1 of HCV was still intact (Fig 6A). Interestingly, NPHV-
delta-UUGGCG, but not HCV variants, could produce infectious viruses in 293T kidney cells
expressing ApoE (Fig 7C). Since miR-122 is liver specific and remains an important factor for
HCV tropism, the fact that NPHV only requires one molecule of miR-122 could lower the
threshold for NPHV to infect other organs. However, except for sporadic evidence of extrahe-
patic presence of NPHV [18,41], it remains to be determined if replication occurs in other tis-
sues in vivo. Still it remains feasible that low-level replication outside the liver could occur and
influence the course of disease or transmission between hosts.
It was striking, but not surprising, that the fittest HCV variant emerging from our satura-
tion mutagenesis library in wild type Huh-7.5 cells carried the wild type seed sites. This con-
firms that in the Huh-7.5 environment miR-122 binding HCV is indeed the optimal variant
(Fig 5C). Another interesting finding was that HCV-122/15, which we previously predicted
and confirmed to be viable, was also selected in Huh-7.5 cells. HCV therefore appears to func-
tion most efficiently with two miRNA seed sites. While miR-122 could be substituted by other
miRNAs, HCV with two miR-122 sites remains superior. In contrast, NPHV either acquired
the wild type miR-122 site in combination with an adaptive mutation (NPHV-SL1/
miRBRC83A) or carried a 15-nt truncation (NPHV-delta-UUGGCG) in the miRBR. Thus,
miR-122 binding NPHV variants were also selected as long as miR-122 was available.
We were able to isolate NPHV and HCV variants in the ΔmiR-122 Huh-7.5 cells with simi-
lar efficiency (Fig 6A). This makes it likely that during hepacivirus evolution miR-122-indepe-
dent variants have emerged. It is therefore curious why most hepaciviruses isolated thus far
retain at least one miR-122 binding site and hence hepatocyte tropism. Clearly, basic replica-
tive functions can ensue in the absence of miR-122 using alternative 5’UTR structures and/or
binding sites for different miRNAs. We therefore speculate that sampling of hepaciviruses in
nature has been biased to those that can establish chronic infection in their animal hosts.
Retaining miR-122 dependence and restricting replication to hepatocytes may allow these
viruses to take advantage of the tolerogenic liver environment [43,44] to establish and
and NPHV/HCV variants. (B) Quantification of NS5A positive 293T cells post-transfection as in (A) but
compared to a daclatasvir (DCV) treated culture. (C) Infectious virus production from 293T cells with or
without exogenous ApoE expression. Virus titers were quantified by limiting dilution assay on naïve Huh-7.5
cells. In (A)-(C), results represent mean±SEM from 3–6 independent experiments. Asterisks, *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001, Student’s t test.
https://doi.org/10.1371/journal.ppat.1006694.g007
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maintain chronicity. Variants with the ability to replicate in other cell types might be selected
against if they elicit an adaptive immune response that eliminates infection and prevents
chronicity. Consequently, we posit that there may be hepaciviruses in nature that are not
strictly hepatotropic and that these viruses will be more likely to cause acute resolving infec-
tions with different modes of transmission to ensure their survival.
Besides the interaction of miR-122 with the 5’UTR of NPHV, our in vivo AGO-CLIP stud-
ies demonstrated miRNA binding at all three other conserved miR-122 sites in the NPHV
polyprotein coding region (Fig 1B). Unfortunately, we lack the cell culture systems needed to
assess the potential contributions of miRNA binding at these NS5A/5B sites. Thus, it remains
possible that these sites also contribute towards NPHV miR-122 dependence. For HCV, how-
ever, miR-122 sites in the ORF and 3’UTR do not appear to influence viral replication and/or
production [15,45]. It will be interesting to explore this further using infectious clones in vivo,
or after the development of tractable NPHV culture systems [28].
In conclusion, using a panel of NPHV/HCV chimeras, we were able to test the miRNA
dependence of NPHV in cell culture. We demonstrate that one molecule of miR-122 is the
only miRNA that binds the NPHV miRBR region, consistent with our in vivo data. Using
NPHV/HCV chimeras, miR-122 independent variants could be selected that were capable of
extra-hepatic replication. This indicates that the interaction of one molecule of miR-122 with
the NPHV miRBR does contribute to its hepatic tropism but that subtle changes in the NPHV
5’UTR have higher potential to break the tissue tropism barrier as compared to HCV. Given
that most hepaciviruses observed in nature contain at least one miR-122 binding site despite
the fact that minor changes in the miRBR can weaken or even obviate miR-122 dependence
indicates a strong selective pressure to maintain hepatotropism. We suggest that this selective
force is not for basic hepacivirus replicative functions but rather to exploit the tolerogenic liver
environment to orchestrate chronicity.
Materials and methods
Ethics statement
We used NPHV infected liver biopsies from two horses. This did not require euthanasia of any
animal. Ultrasound-guided percutaneous biopsies were taken from horses, using standard pro-
cedures at the College of Veterinary Medicine, Cornell University and adhered to the Institu-
tional Animal Care and Use Committee protocol at this institution.
Construction of NPHV plasmids
NPHV-5’UTR, NPHV-IRES, NPHV-SL1/miRBR, and NPHV-SL1 were constructed in the
HCV J6/JFH Clone2 backbone [29], by replacing the 5’UTR (nt 1–341), IRES (43–341), SL1-
miRBR (1–42), or SL1 (1–20) of HCV by the corresponding sequence of the 5’UTR (1–384),
IRES(103–384), SL1-miRBR (1–102) or SL1(1–74) of the NZP1 NPHV isolate [28]. HCV-122/
15 and HCV-S2-GGCGUG were constructed by replacing seed site 2 of HCV (37–42) with the
miR-15 binding site (GCTGCT) or GGCGTG, respectively. SL1-miRBRC83A, NPHV-
GGCAGG, and NPHV-delta-UUGGCG were constructed from NPHV-SL1/miRBR by
introducing single mutations or exchanging the miRBR site (also see Fig 5C). NPHV-SL1/
miRBR-m15 was constructed by replacing the miR-122 binding site at position of 96–101 of
NPHV-SL1/miRBR with the miR-15 binding site (GCTGCT). For TRIP-hApoE3shres-
TagRPF, the cDNA clone of human apolipoprotein E (NM_001302691) was amplified from
Huh-7.5 cDNA using the primers RU-O-19451 and RU-O-19452 that contains MluI and
BamHI sites. This was then cloned into pDONOR221 (Fisher Scientific), which was linearized
by the same pair of endonucleases. All primer sequences are listed in S1 Table.
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Cell culture
Huh-7.5 [46] and ΔmiR-122 Huh-7.5 hepatoma cells [15], derived previously in our labora-
tory, were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen) supple-
mented with 0.1 mM nonessential amino acids (Invitrogen) and 5% fetal bovine serum (FBS).
293T cells (ATCC) were maintained in DMEM supplemented with 10% FBS and 0.1 mM
NEAA as described [47]. ΔDICER Huh-7.5 hepatoma cells were generated as described below
and maintained in DMEM supplemented with 10% FBS and 0.1 mM NEAA. To produce
293T-ApoE, 293T cells were transduced with lentiviruses produced from pTRIP-hAp-
oE3shres-TagRFP in a 293T producer culture, as previously described [37]. Efficiency of trans-
duction was confirmed by the percentage of RFP positive cells before further analysis. Three
different 293T cell lines derived from single colonies of 293T cells were tested to confirm the
consistent observation of NS5A positive cells with NPHV-delta-UUGGCG. For Daclatasvir
(DCV) treatment, 293T cells were pre-incubated with 10 nM of DCV (100-fold EC50[48]) one
day before transfection with viral RNA.
CRISPR mediated deletion of DICER in Huh-7.5 cells
To make ΔDICER Huh-7.5 cells, we deleted exons 2 and 19 in the DICER gene in Huh-7.5
cells described above. Guide sequence pairings were as follows: Dicer.sgRNAEX2.1a with
Dicer.sgRNAEX2.1b, Dicer.sgRNAEX2.2a with Dicer.sgRNAEX2.2b, Dicer.sgRNAEX19.1a
with Dicer.sgRNAEX19.1b, and Dicer.sgRNAEX19.2a with Dicer.sgRNAEX19.2b. Guide
RNAs were cloned into pX458-SpCas9-(BB)-2A-GFP (Addgene, #48138). After sequence con-
firmation, transfection and single cell dilution, cloning proceeded as previously described [15].
To genotype single cell clones and to approximate editing efficiency in bulk cells, DNA was
extracted using QuickExtract (Epicenter) and DICER exon 2 and 19 loci were PCR amplified
using primers DicerEX2_GenomicF with DicerEX2_GenomicR, and DicerEX19_GenomicF
with DicerEX19_GenomicR, respectively. The resulting PCR products underwent gel electro-
phoresis. The sole surviving homozygous deletion clone was expanded.
In vitro transcription and RNA transfection
NPHV/HCV and HCV recombinant RNAs were in vitro transcribed from XbaI linearized DNA
plasmids using T7 RiboMAX Express Large Scale RNA Production System (Promega). RNA was
treated with RQ1 DNase (Promega) at 37˚C for 15 min and purified on RNeasy columns (Qiagen).
For transfection of Huh-7.5 based cell lines, 1 μg RNA was mixed with 5 μL Lipofectamine
2000 (Life Technologies) in 500 μL OptiMEM, incubated 10 min and added to 3.5x105 cells in
6-well plates where media was changed to DMEM containing 1.5% FBS and 1% NEAA before
transfection. For transfection of 293T-based cell lines, transfection was performed with 5x105
cells. 10 pmol of miR-122 was co-transfected with viral RNAs where indicated. To increase the
transfection efficiency, cells were then spinoculated for 30 min at 37˚C with 1000 g. Cells were
split every 2 days, 1/3 of cells were seeded for the next time point, 2/3 of cells were pelleted,
fixed with 2% PFA, and used for flow cytometry detection of HCV NS5A expression by stain-
ing with the 9E10 antibody conjugated with Alexa 647. Supernatant aliquots were stored at
-80˚C for virus titration assays (TCID50). HCV infectious titers were determined by a limiting
dilution assay on naïve Huh-7.5 cells as previously described [49].
Saturated mutagenesis assay
To generate saturated libraries of NPHV-Rand and HCV-Rand containing all possible combi-
nations of nucleotides in the randomized region, we constructed bacterial transformation
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libraries with at least 10 times more colonies than the combination of all possible nucleotides
(4^6 = 4096). Briefly, we introduced randomized seed sites into NPHV-SL1/miRBR and HCV
by PCR with RU-O-21135 and RU-O-17131 or RU-O-21134 and RU-O-17131, respectively.
After restriction digest with NotI and KpnI, the PCR product was ligated into the parental plas-
mid and transformed into DH10B with electroporation transformation. After transformation,
cells were revived in 500 μl SOC medium. 2 μl were spread on P10 LB medium to count colo-
nies. To minimize potential bias of bacterial growth, bacteria were spread onto 2xP500 LB
plates. After overnight incubation, cells were scraped into 20 ml LB medium and plasmids
were purified with Plasmid Maxi-prep kit (Qiagen) without further expansion.
Sequencing of viral RNA from supernatants
For selected viruses, as indicated in the main text and figures, the 5’UTRs of viruses present in
the supernatant was sequenced using 5’RACE according to manufacturers protocol (Invitro-
gen). The primer RU-O-17102 was used for reverse transcription and RU-17104 and RU-
18654 for the subsequent 1st and 2nd PCRs, respectively. PCR products were then cloned into
TOPO-TA vectors (Invitrogen) for sequencing. Corresponding plasmids were included in the
same procedure as negative control.
CLIP assay
Standard AGO-CLIP was done as described [50]. To enable cost-effective multiplexing, we
added sequencing adapters and 5’ indices in the 2nd PCR step using the primers listed in S1
Table. This strategy uses the DP5 and DP3 sequences of the 1st PCR product as priming sites
to add 5’ indices and 3’ adapters for a short (6–16 cycles) 2nd PCR step.
CLEAR-CLIP is based on standard AGO-CLIP with modifications to enrich for miRNA-
target chimeras [30]. Briefly, the following procedures replace the post-immunoprecipita-
tion steps of standard AGO-CLIP: (i) 5’-end phosphorylation using PNK (3’ phosphatase
minus), (ii) Over-night chimera ligation using T4 RNA ligase 1, (iii) Alkaline phosphatase
treatment to remove 3’ phosphate groups, (iv) 3’-linker ligation using truncated T4 RNA
ligase 2 and pre-adenylated linker (using a pre-adenylated linker and omitting the enzyme
in step ii allows negative controls to distinguish cellular vs. on-bead ligation events), and (v)
Radio labeling using T4 PNK and [γ-32P]-ATP. Here, the ligase-free controls used to estab-
lish the method [30] were not needed, and the 3’ linker ligation was therefore done with T4
RNA ligase 1 and a radioactively labeled phosphorylated RNA linker according to the stan-
dard AGO-CLIP protocol [50], and not using truncated T4 RNA ligase 2 and a pre-adeny-
lated linker. Accordingly, the subsequent PNK treatment was done with non-radioactive
ATP.
For in vivo experiments, NPHV infected liver biopsies from two horses were taken and
snap-frozen at the College of Veterinary Medicine, Cornell University adhering to Institu-
tional Animal Care and Use Committee protocols as previously described [28]. Samples were
powderized in liquid nitrogen followed by cross-linking with UV 254nm 3x at 400mJ/cm2.
Results were combined from a 54mg biopsy from day 23 of an acutely infected horse (by intra-
hepatic RNA inoculation, NZP1 strain) with a serum titer of 106.7 GE/mL and a 137mg biopsy
of a chronically NPHV infected horse with a serum titer of 105 GE/mL. Cultured Huh-7.5 cells
for CLIP were transfected with NPHV-SL1/miRBR or NPHV-SL1/miRB-m15 and cross-
linked 4 days post transfection; HCV, NPHV-SL1/miRBRC83A, HCV-S2-GGCGUG, and
NPHV-delta-UUGGCG, either in the absence or presence of miR-122 in ΔDICER Huh-7.5
cells were cross-linked 3 days post transfection.
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RNA degradation assay
1 ‘μg of HCV-p7ns2Gluc-GNN or NPHV-p7ns2Gluc-GNN RNA, synthesized as previously
described [51], was co-transfected in the presence of miR-122 or miR-430 mimic (Dharmacon)
using the transfection protocol described above for ΔDICER Huh-7.5 cells in 6-well plates. At
each time point, cells were washed with PBS 5 times and detached using trypsin. Cells were pel-
leted at 500 g, 4˚C for 5 min and washed once with 1 mL of cold PBS. Cells were then pelleted
under the same conditions and resuspended in 200 μL PBS. Cells were stored at -80˚C or pro-
cessed immediately by adding 1 mL Trizol. Samples were then mixed and 200 μL of chloroform
were added and processed as described. After phase separation, the upper phase (approximately
600 μL) was transferred to another RNase free tube, mixed 1:1 with ethanol (100%) and loaded
on RNeasy mini kit column (Qiagen). RNA was further purified as described and quantified by
a two-step procedure using the QuantiTect Reverse Transcription kit (Qiagen) for cDNA syn-
thesis followed by a qPCR using SYBR Green PCR Master Mix (Applied Biosystems) at 95˚C
for 10 min followed by 40 cycles of 95˚C for 15 sec, 60˚C for 15 sec and 72˚C for 15 sec using
primers RU-O-17104 and RU-O-21903. Standard curves were generated from the same RNAs.
Luciferase reporter assays
RNA transfection was done as described above using NPHV-p7ns2Gluc-GNN and the indi-
cated derivative RNAs. At 6hr post transfection, the supernatant of each well was collected to
assay for Renilla luciferase as described [15] and read on a FLUOstar Omega (BMG Labtech).
Supporting information
S1 Fig. IRES activity of HCV and NPHV variants. Huh-7.5 cells were transfected with repli-
cation-deficient HCV-p7ns2Gluc-GNN and NPHV-p7ns2Gluc-GNN variant RNAs, as indi-
cated. At 6hr post transfection, the supernatant of each well was collected to assay for Renilla
activity. All values were normalized to the HCV control. Data represent the mean (±SEM) of
three independent experiments.
(EPS)
S2 Fig. Comparison of predicted secondary structures of miRBR region within HCV and
NPHV constructs. The nucleotides corresponding to stem loop 1 (SL1) and microRNA bind-
ing region (miRBR) of NPHV (A-D) and HCV (E-G) are shown and folded using Mfold [52]
(available at http://mfold.rna.albany.edu/?q=mfold). Mutagenized sites (A,B,E,F) and altered
microRNA-122 binding sites (C,D,G) are boxed.
(EPS)
S1 Table. Sequence of oligonucleotides.
(XLSX)
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